Venetoclax is under clinical development by AbbVie and currently in Phase I for Primary Mediastinal B-Cell Lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback